Shares of eHealth, Inc. (NASDAQ:EHTH – Get Free Report) have earned a consensus rating of “Reduce” from the six ratings firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and five have issued a hold recommendation on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $2.19.
EHTH has been the subject of several research reports. Weiss Ratings restated a “sell (d)” rating on shares of eHealth in a report on Thursday, August 13th. UBS Group cut their price objective on eHealth from $2.00 to $1.75 and set a “neutral” rating on the stock in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada cut their price objective on eHealth from $3.00 to $2.00 and set a “sector perform” rating on the stock in a research report on Tuesday, August 25th.
Get Our Latest Stock Report on EHTH
Insider Activity
In other news, Director Francis Soistman, Jr. sold 37,297 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $1.05, for a total value of $39,161.85. Following the completion of the transaction, the director owned 1,015,221 shares in the company, valued at $1,065,982.05. This trade represents a 3.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 94,899 shares of company stock valued at $95,893. 7.20% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On eHealth
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nantahala Capital Management LLC bought a new stake in shares of eHealth during the 2nd quarter valued at $2,624,547. Palo Alto Investors LP bought a new position in eHealth during the 2nd quarter valued at approximately $2,209,368. BlackRock Inc. bought a new position in eHealth during the 2nd quarter valued at approximately $2,000,000. GSA Capital Partners LLP bought a new position in eHealth during the 2nd quarter valued at approximately $494,000. Finally, Assenagon Asset Management S.A. raised its stake in eHealth by 80.5% during the second quarter. Assenagon Asset Management S.A. now owns 472,569 shares of the financial services provider’s stock valued at $704,000 after buying an additional 210,716 shares during the last quarter. Hedge funds and other institutional investors own 79.54% of the company’s stock.
eHealth Price Performance
Shares of EHTH stock opened at $0.55 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 5.12 and a current ratio of 5.12. eHealth has a fifty-two week low of $0.54 and a fifty-two week high of $5.89. The firm has a market cap of $17.61 million, a P/E ratio of -0.47 and a beta of 1.63. The business’s 50 day moving average price is $0.88 and its 200-day moving average price is $1.34.
eHealth (NASDAQ:EHTH – Get Free Report) last announced its earnings results on Tuesday, August 4th. The financial services provider reported ($1.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.84) by ($0.34). eHealth had a net margin of 5.42% and a return on equity of 6.13%. The business had revenue of $33.57 million for the quarter, compared to the consensus estimate of $33.28 million. On average, equities research analysts anticipate that eHealth will post 0.80 earnings per share for the current year.
eHealth Company Profile
eHealth, Inc operates an online health insurance marketplace that helps consumers compare and enroll in health insurance plans. Through its digital platform and licensed insurance agents, the company provides information about plan benefits, coverage options and enrollment requirements from participating insurance carriers.
The company’s principal offerings include Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans. It has also historically offered individual and family health insurance, as well as certain small-business health coverage options.
Recommended Stories
- Five stocks we like better than eHealth
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for eHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eHealth and related companies with MarketBeat.com's FREE daily email newsletter.
